# OCTA in Epivascular Glia After Dex Implant

> **NCT05600179** · — · COMPLETED · sponsor: **Federico II University** · enrollment: 38 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Dexamethasone intravitreal implant

## Key facts

- **NCT ID:** NCT05600179
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05600179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05600179, "OCTA in Epivascular Glia After Dex Implant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05600179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*